Contract Bio-manufacturing Organization(CMO) Market Size, Share, Trends & Analysis By Type, Regional Outlook, Industry Insights, Key Players, Applications And Forecast To 2028

  • Category:Pharmaceuticals & Healthcare
  • Published on:May 2021
  • Pages:104
  • Formats:
  • Report Code:36880

Report Summary

Eternity Insights has published a new study on Global Contract Bio-manufacturing Organization(CMO) Market focusing on key segments as by Type (Growth Factors, Interferons, Monoclonal Antibodies, Recombinant Hormones, Vaccines, Insulin, Other), by Application (Autoimmune Diseases, Oncology, Metabolic Diseases, Ophthalmology, Cardiovascular Diseases, Infectious Diseases, Neurology, Respiratory Disorders, Other), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Contract Bio-manufacturing Organization(CMO) Market.

The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.

Contract Bio-manufacturing Organization(CMO) Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.

Global Contract Bio-manufacturing Organization(CMO) Market Size, 2018-2028 (USD Million)

To learn more about this report

Request For Sample

Global Contract Bio-manufacturing Organization(CMO) Market Segmentation:

Contract Bio-manufacturing Organization(CMO) Market, By Type

  • Growth Factors
  • Interferons
  • Monoclonal Antibodies
  • Recombinant Hormones
  • Vaccines
  • Insulin
  • Other

Contract Bio-manufacturing Organization(CMO) Market, By Application

  • Autoimmune Diseases
  • Oncology
  • Metabolic Diseases
  • Ophthalmology
  • Cardiovascular Diseases
  • Infectious Diseases
  • Neurology
  • Respiratory Disorders
  • Other

To learn more about this report

Request For Sample

Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Contract Bio-manufacturing Organization(CMO) market in terms of demand generation. The Contract Bio-manufacturing Organization(CMO) market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Contract Bio-manufacturing Organization(CMO) market for below listed coun-tries across each region.

North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).

Global Contract Bio-manufacturing Organization(CMO) Market Taxonomy:

To learn more about this report

Request For Sample

Global Contract Bio-manufacturing Organization(CMO) Market Competitive Landscape

The global Contract Bio-manufacturing Organization(CMO) market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details

  • Company Overview
  • Financial Analysis
  • Product Portfolio Analysis
  • Strategic Overview
  • SWOT Analysis

List of Companies Profiled in the report:

  • Abzena
  • Althea
  • Asymchem Laboratories Inc.
  • Baxter Biopharma Solutions
  • Biomeva
  • Boehringer Ingelheim
  • Celltrion
  • CMC Biologics
  • Cytovance Biologics
  • Fujifilm Diosynth Technologies
  • KBI Biopharma
  • Lonza Group
  • MicroProtein Technologies
  • Patheon
  • Porton Pharma Solutions
  • Probiogen
  • Rader
  • Rentschler Biotechnologie
  • Samsung
  • Sandoz
  • STA Pharmaceutical Co. Ltd
  • WuXi AppTec
  • Other Players of Specific Interest can be added based on requirement

Market Segmentation

Report Attributes Details
The market size value in 2021 USD XX.XX Million
CAGR (2021 - 2028) XX.XX %
The Revenue forecast in 2028 USD XX.XX Million
Base year for estimation 2021
Historical data 2018-2019
Forecast period 2022-2028
Quantitative units
  • Revenue in USD Million
  • CAGR from 2021 to 2028
Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered By Type Outlook, Application Outlook, Regional Outlook
By Type Outlook Growth Factors, Interferons, Monoclonal Antibodies, Recombinant Hormones, Vaccines, Insulin, Other
By Application Outlook Autoimmune Diseases, Oncology, Metabolic Diseases, Ophthalmology, Cardiovascular Diseases, Infectious Diseases, Neurology, Respiratory Disorders, Other
Regional scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Country scope U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey
Key companies profiled Abzena, Althea, Asymchem Laboratories Inc., Baxter Biopharma Solutions, Biomeva, Boehringer Ingelheim, Celltrion, CMC Biologics, Cytovance Biologics, Fujifilm Diosynth Technologies, KBI Biopharma, Lonza Group, MicroProtein Technologies, Patheon, Porton Pharma Solutions, Probiogen, Rader, Rentschler Biotechnologie,Samsung, Sandoz, STA Pharmaceutical Co. Ltd, WuXi AppTec
Customization Available Yes, the report can be tailored to meet your specific requirements.

Key Benefits to the stake holders

  • Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
  • Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come

Table Of Contents

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Contract Bio-manufacturing Organization(CMO) Market Size Growth Rate by Type (2017-2027)
1.4.2 Growth Factors
1.4.3 Interferons
1.4.4 Monoclonal Antibodies
1.4.5 Recombinant Hormones
1.4.6 Vaccines
1.4.7 Insulin
1.4.8 Other
1.5 Market by Application
1.5.1 Global Contract Bio-manufacturing Organization(CMO) Market Share by Application (2017-2027)
1.5.2 Autoimmune Diseases
1.5.3 Oncology
1.5.4 Metabolic Diseases
1.5.5 Ophthalmology
1.5.6 Cardiovascular Diseases
1.5.7 Infectious Diseases
1.5.8 Neurology
1.5.9 Respiratory Disorders
1.5.10 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Contract Bio-manufacturing Organization(CMO) Market Size
2.2 Contract Bio-manufacturing Organization(CMO) Growth Trends by Regions
2.2.1 Contract Bio-manufacturing Organization(CMO) Market Size by Regions (2017-2027)
2.2.2 Contract Bio-manufacturing Organization(CMO) Market Share by Regions (2017-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Contract Bio-manufacturing Organization(CMO) Market Size by by Players
3.1.1 Global Contract Bio-manufacturing Organization(CMO) Revenue by by Players (2017-2020)
3.1.2 Global Contract Bio-manufacturing Organization(CMO) Revenue Market Share by by Players (2017-2020)
3.1.3 Global Contract Bio-manufacturing Organization(CMO) Market Concentration Ratio (CR5 and HHI)
3.2 Contract Bio-manufacturing Organization(CMO) Key Players Head office and Area Served
3.3 Key Players Contract Bio-manufacturing Organization(CMO) Product/Solution/Service
3.4 Date of Enter into Contract Bio-manufacturing Organization(CMO) Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Contract Bio-manufacturing Organization(CMO) Market Size by Type (2017-2020)
4.2 Global Contract Bio-manufacturing Organization(CMO) Market Size by Application (2017-2020)

5 United States
5.1 United States Contract Bio-manufacturing Organization(CMO) Market Size (2017-2020)
5.2 Contract Bio-manufacturing Organization(CMO) Key Players in United States
5.3 United States Contract Bio-manufacturing Organization(CMO) Market Size by Type
5.4 United States Contract Bio-manufacturing Organization(CMO) Market Size by Application

6 Europe
6.1 Europe Contract Bio-manufacturing Organization(CMO) Market Size (2017-2020)
6.2 Contract Bio-manufacturing Organization(CMO) Key Players in Europe
6.3 Europe Contract Bio-manufacturing Organization(CMO) Market Size by Type
6.4 Europe Contract Bio-manufacturing Organization(CMO) Market Size by Application

7 China
7.1 China Contract Bio-manufacturing Organization(CMO) Market Size (2017-2020)
7.2 Contract Bio-manufacturing Organization(CMO) Key Players in China
7.3 China Contract Bio-manufacturing Organization(CMO) Market Size by Type
7.4 China Contract Bio-manufacturing Organization(CMO) Market Size by Application

8 Japan
8.1 Japan Contract Bio-manufacturing Organization(CMO) Market Size (2017-2020)
8.2 Contract Bio-manufacturing Organization(CMO) Key Players in Japan
8.3 Japan Contract Bio-manufacturing Organization(CMO) Market Size by Type
8.4 Japan Contract Bio-manufacturing Organization(CMO) Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Contract Bio-manufacturing Organization(CMO) Market Size (2017-2020)
9.2 Contract Bio-manufacturing Organization(CMO) Key Players in Southeast Asia
9.3 Southeast Asia Contract Bio-manufacturing Organization(CMO) Market Size by Type
9.4 Southeast Asia Contract Bio-manufacturing Organization(CMO) Market Size by Application

10 India
10.1 India Contract Bio-manufacturing Organization(CMO) Market Size (2017-2020)
10.2 Contract Bio-manufacturing Organization(CMO) Key Players in India
10.3 India Contract Bio-manufacturing Organization(CMO) Market Size by Type
10.4 India Contract Bio-manufacturing Organization(CMO) Market Size by Application

11 Central & South America
11.1 Central & South America Contract Bio-manufacturing Organization(CMO) Market Size (2017-2020)
11.2 Contract Bio-manufacturing Organization(CMO) Key Players in Central & South America
11.3 Central & South America Contract Bio-manufacturing Organization(CMO) Market Size by Type
11.4 Central & South America Contract Bio-manufacturing Organization(CMO) Market Size by Application

12 International Players Profiles
12.1 Abzena
12.1.1 Abzena Company Details
12.1.2 Company Description and Business Overview
12.1.3 Contract Bio-manufacturing Organization(CMO) Introduction
12.1.4 Abzena Revenue in Contract Bio-manufacturing Organization(CMO) Business (2017-2020)
12.1.5 Abzena Recent Development
12.2 Althea
12.2.1 Althea Company Details
12.2.2 Company Description and Business Overview
12.2.3 Contract Bio-manufacturing Organization(CMO) Introduction
12.2.4 Althea Revenue in Contract Bio-manufacturing Organization(CMO) Business (2017-2020)
12.2.5 Althea Recent Development
12.3 Asymchem Laboratories Inc.
12.3.1 Asymchem Laboratories Inc. Company Details
12.3.2 Company Description and Business Overview
12.3.3 Contract Bio-manufacturing Organization(CMO) Introduction
12.3.4 Asymchem Laboratories Inc. Revenue in Contract Bio-manufacturing Organization(CMO) Business (2017-2020)
12.3.5 Asymchem Laboratories Inc. Recent Development
12.4 Baxter Biopharma Solutions
12.4.1 Baxter Biopharma Solutions Company Details
12.4.2 Company Description and Business Overview
12.4.3 Contract Bio-manufacturing Organization(CMO) Introduction
12.4.4 Baxter Biopharma Solutions Revenue in Contract Bio-manufacturing Organization(CMO) Business (2017-2020)
12.4.5 Baxter Biopharma Solutions Recent Development
12.5 Biomeva
12.5.1 Biomeva Company Details
12.5.2 Company Description and Business Overview
12.5.3 Contract Bio-manufacturing Organization(CMO) Introduction
12.5.4 Biomeva Revenue in Contract Bio-manufacturing Organization(CMO) Business (2017-2020)
12.5.5 Biomeva Recent Development
12.6 Boehringer Ingelheim
12.6.1 Boehringer Ingelheim Company Details
12.6.2 Company Description and Business Overview
12.6.3 Contract Bio-manufacturing Organization(CMO) Introduction
12.6.4 Boehringer Ingelheim Revenue in Contract Bio-manufacturing Organization(CMO) Business (2017-2020)
12.6.5 Boehringer Ingelheim Recent Development
12.7 Celltrion
12.7.1 Celltrion Company Details
12.7.2 Company Description and Business Overview
12.7.3 Contract Bio-manufacturing Organization(CMO) Introduction
12.7.4 Celltrion Revenue in Contract Bio-manufacturing Organization(CMO) Business (2017-2020)
12.7.5 Celltrion Recent Development
12.8 CMC Biologics
12.8.1 CMC Biologics Company Details
12.8.2 Company Description and Business Overview
12.8.3 Contract Bio-manufacturing Organization(CMO) Introduction
12.8.4 CMC Biologics Revenue in Contract Bio-manufacturing Organization(CMO) Business (2017-2020)
12.8.5 CMC Biologics Recent Development
12.9 Cytovance Biologics
12.9.1 Cytovance Biologics Company Details
12.9.2 Company Description and Business Overview
12.9.3 Contract Bio-manufacturing Organization(CMO) Introduction
12.9.4 Cytovance Biologics Revenue in Contract Bio-manufacturing Organization(CMO) Business (2017-2020)
12.9.5 Cytovance Biologics Recent Development
12.10 Fujifilm Diosynth Technologies
12.10.1 Fujifilm Diosynth Technologies Company Details
12.10.2 Company Description and Business Overview
12.10.3 Contract Bio-manufacturing Organization(CMO) Introduction
12.10.4 Fujifilm Diosynth Technologies Revenue in Contract Bio-manufacturing Organization(CMO) Business (2017-2020)
12.10.5 Fujifilm Diosynth Technologies Recent Development
12.11 KBI Biopharma
12.12 Lonza Group
12.13 MicroProtein Technologies
12.14 Patheon
12.15 Porton Pharma Solutions
12.16 Probiogen
12.17 Rader
12.18 Rentschler Biotechnologie
12.19 Samsung
12.20 Sandoz
12.21 STA Pharmaceutical Co. Ltd
12.22 WuXi AppTec

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

Choose License Type

close

categories